Matter Bio ^Company

Matter Bio develops biotechnology platforms focused on maintaining genome integrity to support longer, healthier human lifespans. The company studies how DNA accumulates damage over time from internal and external sources, including mutations, structural variations, and epigenetic changes. Matter Bio designs tools and interventions intended to monitor, model, and ultimately reduce this genomic instability. Their work combines molecular biology, genomics, and computational methods to identify mechanisms that influence aging at the DNA level. The company collaborates with researchers and institutions to translate these findings into therapeutic and diagnostic approaches for longevity. Matter Bio positions its technology for use in age-related disease research, healthspan extension programs, and future clinical development efforts.